Guideline recommended therapies and clinical outcomes according to the risk for recurrent cardiovascular events after an acute coronary syndrome

Back

ESC Premium Access

Guideline recommended therapies and clinical outcomes according to the risk for recurrent cardiovascular events after an acute coronary syndrome

Session: Beta blockers: required in all acute coronary syndromes?

Topic: Treatment

Speaker: Doctor Y. Hammer (Petah Tikva, IL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Yoav Hammer

Rabin Medical Center, Petah Tikva (Israel)

0 follower

5 more presentations in this session

Should we use beta-blockers in all patients after st-segment elevation acute myocardial infarction?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Beta-blockers and cardiovascular outcomes in patients hospitalized for acute coronary syndrome without heart failure

Access

Slides

Video

Effects of selective and nonselective beta-blockers on platelet aggregation in patients with acute coronary syndrome: the PLATE-BLOCK study

Speaker: Doctor F. Ilardi (Napoly, IT)

The effect of optimal medical therapy on hospital discharge on 3-year mortality after acute myocardial infarction in patients undergoing primary percutaneous intervention

Speaker: Assistant Professor Z. Mehmedbegovic (Belgrade, RS)

One year survival benefit of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in acute coronary syndrome undergoing PCI according to left ventricular ejection fraction.

Speaker: Doctor M. Cespon Fernandez (Brussels, BE)

Access the full session

Beta blockers: required in all acute coronary syndromes?

Speakers: Doctor Y. Hammer, Doctor J. Ferreira, Doctor F. Ilardi, Assistant Professor Z. Mehmedbegovic, Doctor M. Cespon Fernandez

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources